Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study
Sergey Yegorov, Irina Kadyrova, Baurzhan Negmetzhanov, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

A review of neurological side effects of COVID-19 vaccination
Roya Hosseini, Nayere Askari
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 56
Metagenomic profiling of nasopharyngeal samples from adults with acute respiratory infection
Nurlan Sandybayev, Vyacheslav Beloussov, Vitaliy Strochkov, et al.
Royal Society Open Science (2024) Vol. 11, Iss. 7
Open Access | Times Cited: 4
AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection
Anastasia A. Aksyuk, Himanshu Bansal, Deidre Wilkins, et al.
Cell Reports Medicine (2022) Vol. 4, Iss. 1, pp. 100882-100882
Open Access | Times Cited: 18
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated
Jill Maaske, Stephanie Sproule, Ann R. Falsey, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 11
Application of MALDI-TOF MS and machine learning for the detection of SARS-CoV-2 and non-SARS-CoV-2 respiratory infections
Sergey Yegorov, Irina Kadyrova, Ilya Korshukov, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 5
Open Access | Times Cited: 3
High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination
Irina Kadyrova, Sergey Yegorov, Baurzhan Negmetzhanov, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0272008-e0272008
Open Access | Times Cited: 16
Global Emergence of SARS-CoV2 Infection and Scientific Interventions to Contain its Spread
Himanshu Ajmera, Sudarshan Singh Lakhawat, Naveen Malik, et al.
Current Protein and Peptide Science (2024) Vol. 25, Iss. 4, pp. 307-325
Closed Access | Times Cited: 2
Sputnik V-induced Antibodies against SARS-CoV-2 Variants during the Dissemination of the Gamma Variant in Venezuela
Christopher Franco, Alejandro Cornejo, Mariajosé Rodríguez, et al.
(2024)
Open Access | Times Cited: 2
Establishing the parameters of the operation mode of the electric pulse automobile muffler
Aliya Kukesheva, Adil Kadyrov, Yevgeniy Kryuchkov
Istrazivanja i projektovanja za privredu (2024) Vol. 22, Iss. 2, pp. 89-99
Open Access | Times Cited: 1
The impact of Gam-COVID-Vac, an Adv5/Adv26 COVID-19 vaccine, on the biomarkers of endothelial function, coagulation and platelet activation
Anar Turmukhambetova, Sergey Yegorov, Ilya Korshukov, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0293074-e0293074
Open Access | Times Cited: 4
The nasopharyngeal virome in adults with acute respiratory infection
Nurlan Sandybayev, Vyacheslav Beloussov, Vitaliy Strochkov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Comparative immunogenicity and safety of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines: results of a pilot clinical study
И. О. Стома, K. S. Korsak, Е. В. Воропаев, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21877-e21877
Open Access | Times Cited: 3
The impact of Gam-COVID-Vac, an AdV5/AdV26 COVID-19 vaccine, on the biomarkers of endothelial function, coagulation and platelet activation
Anar Turmukhambetova, Sergey Yegorov, Ilya Korshukov, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
COVID-19 Vaccination and Lethality Reduction: A Prospective Cohort Study in Venezuela
David A. Forero‐Peña, Jéssica L. Leyva, María V. Valenzuela, et al.
Research Square (Research Square) (2024)
Open Access
Sputnik V-Induced Antibodies against SARS-CoV-2 Variants during the Dissemination of the Gamma Variant in Venezuela
Christopher Franco, Alejandro Cornejo, Mariajosé Rodríguez, et al.
Viruses (2024) Vol. 16, Iss. 9, pp. 1480-1480
Open Access
COVID-19 vaccination and lethality reduction: a prospective observational study in Venezuela during the last two waves
David A. Forero‐Peña, Jéssica L. Leyva, María V. Valenzuela, et al.
Deleted Journal (2024) Vol. 21, Iss. 1
Open Access
RBD-specific antibody response after two doses of different SARS-CoV-2 vaccines during the mass vaccination campaign in Mongolia
Burenjargal Batmunkh, Otgonbayar Dashpagma, Shatar Shaarii, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0295167-e0295167
Open Access | Times Cited: 1
Sustained Delivery of a Monoclonal Antibody against SARS-CoV-2 by Microencapsulated Cells: A Proof-of-Concept Study
Assem Ashimova, Askhat Myngbay, Sergey Yegorov, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2042-2042
Open Access | Times Cited: 1
Oro-Facial Manifestations of COVID-19 Vaccines: A Systematic Review
Simran Kaur, Manisha Sharma
Saudi Journal of Oral and Dental Research (2023) Vol. 8, Iss. 06, pp. 191-200
Open Access
Early Side Effects after Administration of the 1st Dose of Oxford-AstraZeneca Vaccine
Pramod Singh, Abdul Rafae Faisal, Maleeha Shah, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top